VIE | Viela Bio Company profile
Company profileViela is dedicated to the development and commercialization of novel, life-changing medicines for patients with a wide range of autoimmune and severe inflammatory diseases. We believe that our approach ? which targets the underlying molecular pathogenesis of the disease ? enables us to develop more precise therapies, identify patients more likely to respond to treatment and pursue multiple indications for each of our product candidates. Learn more about our clinical pipeline. AddressOne MedImmune Way | NotesJump to (Finance sites)         ResearchInvestor pageir.vielabio.comIf you are looking for News & events, Press Release, they are available on their Investors Relationssite. Their Official Profiles  Support this projectIf you want to help pay for server cost or for improving this tool. You can send it via Paypal. Social MediaRecommended Books Buy on Amazon In the world of investing, slow and steady wins the race. With this mantra in mind, trusted author and finance guru Eric Tyson is back with the latest edition of the #1 bestselling book, Investing For Dummies, to help you achieve your investment goals. |